Table 3.
Percentages resistance of Gram negative uropathogens causing community-acquired urinary tract infections in Tanzania.
| Antibiotic | E. coli | Other Enterobacterales | Non-Enterobacterales | ||||||
|---|---|---|---|---|---|---|---|---|---|
| DAR (n = 53) | MWZ (n = 90) | Overall (n = 143) | DAR (n = 47) | MWZ (n = 31) | Overall (n = 78) | DAR (n = 14) | MWZ (n = 3) | Overall (n = 17) | |
| AMP | 83.0% | 87.8% | 86.0% | 61.7% | 96.8% | 75.6% | NA | NA | NA |
| SXT | 81.1% | 84.4% | 83.2% | 61.7% | 54.8% | 58.9% | 25.0% * | 50.0% * | 30.0% * |
| TCY | 79.3% | 74.4% | 76.2% | 40.4% | 54.8% | 46.2% | 55.6% * | 0.0% * | 45.5% * |
| AMC | 47.2% | 50.2% | 48.9% | 48.9% | 58.1% | 52.6% | NA | NA | NA |
| CIP | 50.9% | 50.0% | 50.4% | 44.7% | 22.6% | 35.9% | 14.3% | 33.3% | 17.7% |
| FEP | 28.3% | 28.9% | 28.7% | 36.2% | 22.6% | 30.8% | 0.0% | 33.3% | 5.9% |
| CAZ | 28.3% | 27.8% | 27.9% | 31.9% | 25.8% | 29.5% | 35.7% | 0.0% | 29.4% |
| CRO | 26.4% | 27.8% | 27.3% | 34.0% | 25.8% | 30.8% | 50.0% * | 0.0% * | 40.0% * |
| GEN | 26.4% | 20.0% | 22.4% | 27.7% | 9.7% | 20.5% | 0.0% | 33.3% | 5.9% |
| NIT | 15.1% | 38.9% | 30.1% | 40.4% | 58.1% | 47.4% | NA | NA | NA |
| IMP | 0.0% | 1.1% | 0.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| MEM | 0.0% | 1.1% | 0.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
KEY: DAR = Dar es Salaam, MWZ = Mwanza, AMP = ampicillin, AMC = amoxicillin-clavulanic acid, CAZ = ceftazidime, CRO = ceftriaxone, FEP = cefepime, IMP = imipenem, MEM = meropenem, GEN = gentamicin, CIP = ciprofloxacin, SXT = trimethoprim-sulfamethoxazole, NIT = nitrofurantoin, TCY = tetracycline, NA = not applicable, GNB = Gram negative bacteria, and * Acinetobacter spp. only (n = 11). Other Enterobacterales included K. pneumoniae (n = 22), Klebsiella oxytoca (n = 6), Enterobacter aerogenes (n = 6), Enterobacter cloacae (n = 2), unidentified GNR (n = 36), Proteus spp. (n = 4) and Morganella morganii (n = 2).